{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:28:37Z","timestamp":1779218917882,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ejphar.2010.04.053","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T10:37:37Z","timestamp":1273660657000},"page":"172-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock"],"prefix":"10.1016","volume":"640","author":[{"given":"Krzysztof","family":"\u0141ukawski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Janowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Jakubus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Tochman-Gawda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.04.053_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0306-4522(00)00209-8","article-title":"The lesional and epileptogenic consequences of lithium\u2013pilocarpine-induced status epilepticus are affected by previous exposure to isolated seizures: effects of amygdala kindling and maximal electroshocks","volume":"99","author":"Andr\u00e9","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2010.04.053_bib2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/088307389701200802","article-title":"Glutamate in neurologic disease","volume":"12","author":"Bittigau","year":"1997","journal-title":"J. Child. Neurol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle methode simple pour explorer l'action \u2018tranquilisante\u2019: le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp. (Basel)"},{"key":"10.1016\/j.ejphar.2010.04.053_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/10641960500298723","article-title":"Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats","volume":"27","author":"Braszko","year":"2005","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ejphar.2010.04.053_bib5","first-page":"271","article-title":"Effects of angiotensin II and its receptor antagonists on motor activity and anxiety in rats","volume":"54","author":"Braszko","year":"2003","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1152\/ajpregu.00028.2003","article-title":"Responses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism","volume":"285","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(98)00983-2","article-title":"Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats","volume":"367","author":"Culman","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1043-6618(05)80092-1","article-title":"Modulation of the protective efficacy of common antiepileptic drugs by xanthine derivatives: implications for the clinical use of xanthines in epileptic patients","volume":"22","author":"Czuczwar","year":"1990","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2010.04.053_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","article-title":"The new generation of GABA enhancers","volume":"15","author":"Czuczwar","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2010.04.053_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0014-2999(85)90449-2","article-title":"Antagonism of N-methyl-D, L-aspartic acid-induced convulsions by antiepileptic drugs and other agents","volume":"108","author":"Czuczwar","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(98)00632-3","article-title":"LY 300164, a novel antagonist of AMPA\/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs","volume":"359","author":"Czuczwar","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-1211(97)00033-8","article-title":"Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2010.04.053_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International Union of Pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2010.04.053_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2003.08.015","article-title":"Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats","volume":"123","author":"Ealls","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2010.04.053_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1523-1755.2005.00290.x","article-title":"An extremely high dose of losartan affords superior renoprotection in the remnant model","volume":"67","author":"Fujihara","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2010.04.053_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0306-4522(91)90073-W","article-title":"Autoradiographic localization of subtypes of angiotensin II antagonist binding in the rat brain","volume":"44","author":"Gehlert","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2010.04.053_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0143-4179(86)90026-0","article-title":"Interactions between angiotensin II. GABA and diazepam in convulsive seizures","volume":"7","author":"Georgiev","year":"1986","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2010.04.053_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0143-4179(91)90146-A","article-title":"Interactions between angiotensin II, diazepam, clonazepam and di-n-propylacetate in pentylenetetrazol kindling seizures in mice","volume":"18","author":"Georgiev","year":"1991","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2010.04.053_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0143-4179(95)90071-3","article-title":"Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice","volume":"28","author":"Georgiev","year":"1995","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2010.04.053_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0143-4179(96)90000-1","article-title":"Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice","volume":"30","author":"Georgiev","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2010.04.053_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.04.053_bib22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00019052-199804000-00008","article-title":"Mechanisms and experimental models of seizure generation","volume":"11","author":"Jefferys","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.brainresbull.2003.10.011","article-title":"Inhibitory effects of angiotensin on NMDA-induced cytotoxicity in primary neuronal cultures","volume":"62","author":"Jing","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2010.04.053_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/phrs.1996.0073","article-title":"Losartan influences behavioural effects of angiotensin II in rats","volume":"34","author":"Ku\u0142akowska","year":"1996","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2010.04.053_bib25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.04.053_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate","volume":"10","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2010.04.053_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2010.04.053_bib28","first-page":"782","article-title":"How significant is the difference between drug doses influencing the threshold for electroconvulsions?","volume":"57","author":"Luszczki","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2010.04.053_bib29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1528-1157.2003.32702.x","article-title":"Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis","volume":"44","author":"Luszczki","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2010.04.053_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neuro.2009.10.002","article-title":"Roles of perirhinal and posterior piriform cortices in control and generation of seizures: a microinfusion study in rats exposed to soman","volume":"31","author":"Myhrer","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejphar.2010.04.053_bib31","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0143-4179(98)90065-8","article-title":"Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory","volume":"32","author":"Raghavendra","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2010.04.053_bib32","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2010.04.053_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/030079905X75041","article-title":"Angiotensin II antagonists\u2014therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy","volume":"22","author":"Ribeiro","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejphar.2010.04.053_bib34","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1523\/JNEUROSCI.07-06-01866.1987","article-title":"Resolving GABAA\/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies","volume":"7","author":"Richards","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2010.04.053_bib35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-6997(25)00046-8","article-title":"Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds","volume":"42","author":"Rogawski","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2010.04.053_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1684\/j.1950-6945.2001.tb00392.x","article-title":"Update on the mechanisms of action of antiepileptic drugs","volume":"3","author":"Sills","year":"2001","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.ejphar.2010.04.053_bib37","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1476-5381.1991.tb12503.x","article-title":"Access of peripherally administered DuP 753 to rat brain angiotensin II receptors","volume":"104","author":"Song","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0928-4257(99)80151-X","article-title":"Adenosine\u2013angiotensin II interactions in pentylenetetrazol seizure threshold in mice","volume":"93","author":"Tchekalarova","year":"1999","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.ejphar.2010.04.053_bib39","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.lfs.2004.10.012","article-title":"Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?","volume":"76","author":"Tchekalarova","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.04.053_bib40","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0361-9230(01)00568-8","article-title":"Angiotensin III and IV influence on pentylenetetrazol seizure susceptibility (threshold and kindling). Interaction with adenosine A1 receptors","volume":"56","author":"Tchekalarova","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2010.04.053_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0741-8329(97)00157-2","article-title":"Losartan blocks diazepam and ethanol effects on air righting","volume":"16","author":"Tracy","year":"1998","journal-title":"Alcohol"},{"key":"10.1016\/j.ejphar.2010.04.053_bib42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0031-6997(25)00446-6","article-title":"Angiotensin II receptor and angiotensin II receptor antagonists","volume":"45","author":"Timmermans","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2010.04.053_bib43","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and \u03b2-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2010.04.053_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00005344-200304000-00012","article-title":"Central nervous system blockade by peripheral administration of AT1 receptor blockers","volume":"41","author":"Wang","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1159\/000078950","article-title":"Safety and tolerability of high-dose angiotensin receptor blocker therapy in patients with chronic kidney disease: a pilot study","volume":"24","author":"Weinberg","year":"2004","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2010.04.053_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-0173(97)00019-2","article-title":"Important roles for angiotensin III and IV in the brain rennin\u2013angiotensin system","volume":"25","author":"Wright","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2010.04.053_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2007.10.009","article-title":"Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets","volume":"84","author":"Wright","year":"2008","journal-title":"Prog. Neurobiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910003857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910003857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:59:58Z","timestamp":1762142398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910003857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":47,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0014299910003857"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.04.053","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}